Skip to main content

Advertisement

SpringerLink
Log in

Platelet derived growth factor and subarachnoid haemorrage: A study on cisternal cerebrospinal fluid

  • Clinical Articles
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

Platelet derived growth factor (PDGF) was identified as a powerful mitogenic growth factor which is released from activated platelets and has a marked activity as vasoconstrictor agent. In the present study we have measured cisternal cerebrospinal fluid (CSF) levels of PDGF in 72 patients operated on for intracranial aneurysm in order to verify whether it might be related to the clinical aspects of SAH with special regard to symptomatic vasospasm.

CSF samples were obtained at surgery by cisternal puncture of the subarachnoid cistern the nearest to the aneurysm before aneurysm isolation and exclusion. The specimen were frozen in liquid nitrogen and stored at-80 ° C until analysis. PDGF was measured using a commercially available reagent. Values are expressed as pg/ml of CSF.

In 18 cases no radiological and clinical signs of SAH were detected and the mean cisternal CSF level of PDGF was 885.0±104.5 pg/ml; 20 patients were operated on between day 1 and 3 from the last SAH episode: mean cisternal CSF level of PDGF was 1917.5±459.4 pg/ml. In 34 patients treated with delayed surgery protocol, mean cisternal CSF level of PDGF was 995.3±73.8 pg/ml. Statistical analysis showed significant differences between groups (P: 0.011). In the subgroup of patients operated on within day 3 after SAH, 6 presented vasospasm and had mean cisternal CSF PDGF level which was significantly higher (P<0.01) than in 14 patients without vasospasm. In the delayed “surgical” patients there was no significant difference in cisternal CSF levels of PDGF considering the occurrence of vasospasm.

The results of the present study suggest that (a) after SAH there is a significant release of PDGF early after SAH and (b) higher levels of PDGF found in cisternal CSF of patients operated on within 72 hours after SAH may be predictive of symptomatic vasospasm.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Berk BC, Alexander RW, Brock TA, Gimbrone MA, Webb CR (1986) Vasoconstriction: a new activity for platelet-derived growth factor. Science 232: 87–90

    Google Scholar 

  2. Chan RC (1984) The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit. J Neurosurg 61:1120–1128

    Google Scholar 

  3. Fein JM, Flor WJ, Cohan SL, Parkhurst J (1974) Sequential changes of vascular ultrastructure in experimental vasospasm. J Neurosurg 41: 49–58

    Google Scholar 

  4. Fisher CM, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6: 1–9

    Google Scholar 

  5. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R (1995) Hemostasis in spontaneous subarachnoid hemorrhage. Neurosurgery 37: 226–234

    Google Scholar 

  6. Gaetani P, Marzatico F, Rodriguez y Baena R, Pacchiarini L, Viganò T, Grignani G, Crivellari MT, Benzi G (1990) Arachi-donic acid metabolism and pathophysiological aspects of sub-arachnoid hemorrhage in rats. Stroke 21: 328–332

    Google Scholar 

  7. Gaetani P, Rodriguez y Baena R, Grignani G, Spanu G, Pacchiarini L, Paoletti P (1994) Endothelin and aneurysmal subarachnoid hemorrhage: a study of subarachnoid cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 57: 66–72

    Google Scholar 

  8. Habenicht AJR, Goerig M, Grulich J, Rothe D, Gronwald R, Loth U, Schettler G, Kommerell B, Ross R (1985) Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxy-genase. J Clin Invest 75: 1381–1387

    Google Scholar 

  9. Honma Y, Kita T, Inomata S, Hasui K, Irie K, Nagao S (1993) The platelet-derived growth factor content in cerebrospinal fluid of patients with an aneurysmal subarachnoid hemorrhage. Jpn J Neurosurg (Tokyo) 2: 192–197

    Google Scholar 

  10. Honma Y, Kita T, Inomata S, Hasui K, Irie K, Nagao S, Clower BR, Smith RR (1993) Proliferative angiopathy following sub-arachnoid hemorrhage and platelet-derived growth factor. In: Findlay JM (ed) Cerebral vasospasm. Elsevier, Amsterdam, pp 257–260

    Google Scholar 

  11. Juvela S, Hillbom M, Kaste M (1991) Platelet thromboxane release and delayed cerebral ischemia in patients with sub-arachnoid hemorrhage. J Neurosurg 74: 386–392

    Google Scholar 

  12. Kapp JP, Neill WR, Neill CL, Hodges LR, Smith RR (1982) The three phases of vasospasm. Surg Neurol 18: 40–45

    Google Scholar 

  13. Kassel NF, Sasaki T, Colohan ART, Nazar G (1985) Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16: 562–572

    Google Scholar 

  14. Kohler N, Lipton A (1974) Platelets as a source of fibroblast growth-promoting activity. Exp Cell Res 87: 297–301

    Google Scholar 

  15. Kurimoto M, Nishijima M, Hirashima Y, Endo S, Takaku A (1995) Plasma Platelet-derived Growth Factor-B chain is elevated in patients with extensively large brain tumour. Acta Neurochir (Wien) 137: 182–187

    Google Scholar 

  16. Nister M, Enblad P, Backstorm G, Soderman T, Persson L, Heldin CH, Westermark B (1994) Platelet-derived growth factor (PDGF) in neoplastic and non-neoplastic cystic lesions of the central nervous system and in the cerebrospinal fluid. Br J Cancer 69: 952–956

    Google Scholar 

  17. Ohkuma H, Suzuki S, Kimura M, Sobate E (1991) Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 22: 854–859

    Google Scholar 

  18. Paoletti P, Gaetani P, Grignani G, Pacchiarini E, Silvani V, Rodriguez y Baena R (1988) CSF leukotriene C4 following subarachnoid hemorrhage. J Neurosurg 69: 488–493

    Google Scholar 

  19. Rodriguez y Baena R, Gaetani P, Paoletti P (1988) A study on cisternal CSF levels of arachidonic acid metabolites after aneurysmal subarachnoid hemorrhage. J Neurol Sci 84: 329–335

    Google Scholar 

  20. Ross R, Raines EW, Bowen-Pope DF (1986) The biology of platelet-derived growth factor. Cell 46: 155–169

    Google Scholar 

  21. Sasaki T, Asano T, Takakura K, Sano K, Kassell NF (1984) Nature of the vasoactive substance in CSF from patients with subarachnoid hemorrhage. J Neurosurg 60: 1186–1194

    Google Scholar 

  22. Smith RR, Clower BR, Peeler DF, Yoshioka J (1983) The angiopathy of subarachnoid hemorrhage: angiographic and morphologic correlates. Stroke 14: 240–245

    Google Scholar 

  23. Suzuki S, Sobata E, Iwabuchi T (1981) Prevention of cerebral ischemic symptoms in cerebral vasospasm with Trapidil, an antagonist and selective synthesis inhibitor of thromboxane A2. Neurosurgery 9: 679–685

    Google Scholar 

  24. Suzuki M, Ogawa A, Sakurai Y, Nishino A, Uenohara K, Mizoi K, Yoshimoto T (1992) Thrombin activity in cere-brospinal fluid after subarachnoid hemorrhage. Stroke (letter) 23: 1181–1182

    Google Scholar 

  25. Yamamoto Y, Bernanke DH, Smith RR (1990) Accelerated non-muscle contraction after subarachnoid hemorrhage: cere-brospinal fluid testing in a culture model. Neurosurgery 27: 921–928

    Google Scholar 

  26. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki M (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415

    Google Scholar 

  27. Walker V, Pickard JD, Smythe P, Eastwood S, Perry S (1983) Effects of subarachnoid hemorrhage on intracranial prostaglandins. J Neurol Neurosurg Psychiatry 46: 119–125

    Google Scholar 

  28. Westermark B, Wasteson A (1974) A platelet factor stimulating human normal glial cells. Exp Cell Res 98: 170–174

    Google Scholar 

  29. Westphal M, Hermann HD (1989) Growth factor biology and oncogene activation in human gliomas and their implication for specific therapeutic concepts. Neurosurgery 25: 681–694

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Neurosurgery, Section of Cerebrovascular Neuropathology, IRCCS Policlinico S.Matteo and University of Pavia, Italy

    P. Gaetani, F. Tancioni, F. Tartara & R. Rodriguez y Baena

  2. Department of Internal Medicine, Section of Medical Therapy, IRCCS Policlinico S.Matteo and University of Pavia, Italy

    G. Grignani, E. M. Merlo & A. Brocchieri

Authors
  1. P. Gaetani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Tancioni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Grignani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Tartara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. M. Merlo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Brocchieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Rodriguez y Baena
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gaetani, P., Tancioni, F., Grignani, G. et al. Platelet derived growth factor and subarachnoid haemorrage: A study on cisternal cerebrospinal fluid. Acta neurochir 139, 319–324 (1997). https://doi.org/10.1007/BF01808827

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01808827

Keywords

Search

Navigation